d’Aiello, A.; Bonanni, A.; Vinci, R.; Pedicino, D.; Severino, A.; De Vita, A.; Filomia, S.; Brecciaroli, M.; Liuzzo, G.
Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk. Int. J. Mol. Sci. 2023, 24, 8643.
https://doi.org/10.3390/ijms24108643
AMA Style
d’Aiello A, Bonanni A, Vinci R, Pedicino D, Severino A, De Vita A, Filomia S, Brecciaroli M, Liuzzo G.
Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk. International Journal of Molecular Sciences. 2023; 24(10):8643.
https://doi.org/10.3390/ijms24108643
Chicago/Turabian Style
d’Aiello, Alessia, Alice Bonanni, Ramona Vinci, Daniela Pedicino, Anna Severino, Antonio De Vita, Simone Filomia, Mattia Brecciaroli, and Giovanna Liuzzo.
2023. "Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk" International Journal of Molecular Sciences 24, no. 10: 8643.
https://doi.org/10.3390/ijms24108643
APA Style
d’Aiello, A., Bonanni, A., Vinci, R., Pedicino, D., Severino, A., De Vita, A., Filomia, S., Brecciaroli, M., & Liuzzo, G.
(2023). Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk. International Journal of Molecular Sciences, 24(10), 8643.
https://doi.org/10.3390/ijms24108643
